Click for best price
Hepatitis B Virus HBV Market Size, Share 2022
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
This report contains market size and forecasts of Hepatitis B Virus (HBV) in Global, including the following market information:
Global Hepatitis B Virus (HBV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B Virus (HBV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Virus (HBV) include Merck, Gilead Sciences, Novartis, GlaxoSmithKline, Hoffmann, La Roche and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Virus (HBV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Virus (HBV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, by Type, 2021 (%)
Therapeutics
Vaccine
Global Hepatitis B Virus (HBV) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Hepatitis B Virus (HBV) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Virus (HBV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B Virus (HBV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
| Report Attributes |
Report Details |
| Report Title |
Hepatitis B Virus (HBV) Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Virus (HBV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Virus (HBV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Virus (HBV) Overall Market Size
2.1 Global Hepatitis B Virus (HBV) Market Size: 2021 VS 2028
2.2 Global Hepatitis B Virus (HBV) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Virus (HBV) Players in Global Market
3.2 Top Global Hepatitis B Virus (HBV) Companies Ranked by Revenue
3.3 Global Hepatitis B Virus (HBV) Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Virus (HBV) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis B Virus (HBV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Virus (HBV) Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Virus (HBV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Virus (HBV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatitis B Virus (HBV) Market Size Markets, 2021 & 2028
4.1.2 Therapeutics
4.1.3 Vaccine
4.2 By Type - Global Hepatitis B Virus (HBV) Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Virus (HBV) Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis B Virus (HBV) Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Virus (HBV) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Hepatitis B Virus (HBV) Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Virus (HBV) Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis B Virus (HBV) Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis B Virus (HBV) Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis B Virus (HBV) Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Virus (HBV) Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis B Virus (HBV) Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatitis B Virus (HBV) Revenue, 2017-2028
6.3.2 US Hepatitis B Virus (HBV) Market Size, 2017-2028
6.3.3 Canada Hepatitis B Virus (HBV) Market Size, 2017-2028
6.3.4 Mexico Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Virus (HBV) Revenue, 2017-2028
6.4.2 Germany Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4.3 France Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4.4 U.K. Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4.5 Italy Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4.6 Russia Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4.7 Nordic Countries Hepatitis B Virus (HBV) Market Size, 2017-2028
6.4.8 Benelux Hepatitis B Virus (HBV) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Virus (HBV) Revenue, 2017-2028
6.5.2 China Hepatitis B Virus (HBV) Market Size, 2017-2028
6.5.3 Japan Hepatitis B Virus (HBV) Market Size, 2017-2028
6.5.4 South Korea Hepatitis B Virus (HBV) Market Size, 2017-2028
6.5.5 Southeast Asia Hepatitis B Virus (HBV) Market Size, 2017-2028
6.5.6 India Hepatitis B Virus (HBV) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatitis B Virus (HBV) Revenue, 2017-2028
6.6.2 Brazil Hepatitis B Virus (HBV) Market Size, 2017-2028
6.6.3 Argentina Hepatitis B Virus (HBV) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue, 2017-2028
6.7.2 Turkey Hepatitis B Virus (HBV) Market Size, 2017-2028
6.7.3 Israel Hepatitis B Virus (HBV) Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatitis B Virus (HBV) Market Size, 2017-2028
6.7.5 UAE Hepatitis B Virus (HBV) Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Hepatitis B Virus (HBV) Major Product Offerings
7.1.4 Merck Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Hepatitis B Virus (HBV) Major Product Offerings
7.2.4 Gilead Sciences Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.2.5 Gilead Sciences Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Hepatitis B Virus (HBV) Major Product Offerings
7.3.4 Novartis Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Hepatitis B Virus (HBV) Major Product Offerings
7.4.4 GlaxoSmithKline Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Hoffmann
7.5.1 Hoffmann Corporate Summary
7.5.2 Hoffmann Business Overview
7.5.3 Hoffmann Hepatitis B Virus (HBV) Major Product Offerings
7.5.4 Hoffmann Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.5.5 Hoffmann Key News
7.6 La Roche
7.6.1 La Roche Corporate Summary
7.6.2 La Roche Business Overview
7.6.3 La Roche Hepatitis B Virus (HBV) Major Product Offerings
7.6.4 La Roche Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.6.5 La Roche Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Hepatitis B Virus (HBV) Major Product Offerings
7.7.4 Bristol-Myers Squibb Hepatitis B Virus (HBV) Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis B Virus (HBV) Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Virus (HBV) Market Drivers in Global Market
Table 3. Hepatitis B Virus (HBV) Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Virus (HBV) in Global Market
Table 5. Top Hepatitis B Virus (HBV) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis B Virus (HBV) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis B Virus (HBV) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis B Virus (HBV) Product Type
Table 9. List of Global Tier 1 Hepatitis B Virus (HBV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Virus (HBV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis B Virus (HBV) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis B Virus (HBV) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Hepatitis B Virus (HBV) Product Offerings
Table 32. Merck Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences Corporate Summary
Table 34. Gilead Sciences Hepatitis B Virus (HBV) Product Offerings
Table 35. Gilead Sciences Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Hepatitis B Virus (HBV) Product Offerings
Table 38. Novartis Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Hepatitis B Virus (HBV) Product Offerings
Table 41. GlaxoSmithKline Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
Table 42. Hoffmann Corporate Summary
Table 43. Hoffmann Hepatitis B Virus (HBV) Product Offerings
Table 44. Hoffmann Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
Table 45. La Roche Corporate Summary
Table 46. La Roche Hepatitis B Virus (HBV) Product Offerings
Table 47. La Roche Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Hepatitis B Virus (HBV) Product Offerings
Table 50. Bristol-Myers Squibb Hepatitis B Virus (HBV) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatitis B Virus (HBV) Segment by Type in 2021
Figure 2. Hepatitis B Virus (HBV) Segment by Application in 2021
Figure 3. Global Hepatitis B Virus (HBV) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Virus (HBV) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis B Virus (HBV) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Virus (HBV) Revenue in 2021
Figure 8. By Type - Global Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 12. US Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 24. China Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hoffmann Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. La Roche Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
